S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip

Larimar Therapeutics (LRMR) Short Interest Ratio & Short Volume

$7.05
-0.19 (-2.62%)
(As of 04/17/2024 ET)

Larimar Therapeutics Short Interest Data

Current Short Volume
3,190,000 shares
Previous Short Volume
1,630,000 shares
Change Vs. Previous Month
+95.71%
Dollar Volume Sold Short
$24.21 million
Short Interest Ratio / Days to Cover
5.5
Last Record Date
March 31, 2024
Outstanding Shares
63,800,000 shares
Percentage of Shares Shorted
5.00%
Today's Trading Volume
281,333 shares
Average Trading Volume
571,818 shares
Today's Volume Vs. Average
49%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Larimar Therapeutics ?

Sign up to receive the latest short interest report for Larimar Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LRMR Short Interest Over Time

LRMR Days to Cover Over Time

LRMR Percentage of Float Shorted Over Time

Larimar Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20243,190,000 shares $24.21 million +95.7%N/A5.5 $7.59
3/15/20241,630,000 shares $14.18 million +221.6%N/A2.9 $8.70
2/29/2024506,800 shares $5.83 million -18.0%N/A1.1 $11.50
2/15/2024618,200 shares $8.21 million +82.0%3.5%1.5 $13.28
1/31/2024339,700 shares $1.97 million -4.9%N/A2.2 $5.79
1/15/2024357,100 shares $1.65 million -8.4%N/A2.8 $4.61
12/31/2023390,000 shares $1.77 million -4.0%N/A3 $4.55
12/15/2023406,100 shares $1.71 million -16.5%N/A4.1 $4.22
11/30/2023486,400 shares $1.67 million -7.8%N/A4.6 $3.43
11/15/2023527,400 shares $1.55 million -8.6%N/A4.8 $2.93
10/31/2023576,900 shares $1.69 million +0.2%N/A4.9 $2.93
10/15/2023575,600 shares $1.69 million -11.3%N/A2.7 $2.93
9/30/2023648,700 shares $2.56 million +7.9%N/A3.2 $3.95
9/15/2023601,100 shares $2.55 million -5.1%N/A2.9 $4.24
8/31/2023633,200 shares $2.36 million +9.9%N/A2.3 $3.72
8/15/2023576,200 shares $2.41 million -12.9%N/A2 $4.18
7/31/2023661,800 shares $2.83 million +3.8%N/A1.8 $4.28
7/15/2023637,500 shares $2.05 million +7.3%N/A2.3 $3.21
6/30/2023594,100 shares $1.86 million +296.3%N/A2.1 $3.13
6/15/2023149,900 shares $509,660.00 -23.9%N/A0.5 $3.40
5/31/2023197,000 shares $726,930.00 -12.0%N/A0.8 $3.69
5/15/2023223,800 shares $803,442.00 -14.3%N/A0.8 $3.59
4/30/2023261,000 shares $1.23 million -14.1%N/A1.2 $4.73
4/15/2023303,700 shares $1.38 million -1.2%N/A1.4 $4.53
3/31/2023307,500 shares $1.39 million -12.4%N/A1.5 $4.53
3/15/2023350,900 shares $2.03 million +3.0%N/A2 $5.79
2/28/2023340,600 shares $2.06 million +43.3%N/A1.9 $6.06
2/15/2023237,700 shares $1.41 million -6.2%N/A1.6 $5.93
1/31/2023253,300 shares $1.25 million -0.2%N/A2.2 $4.94
1/15/2023253,900 shares $1.18 million -1.1%N/A2.4 $4.65
12/30/2022256,800 shares $1.06 million -25.4%N/A2.4 $4.13
12/15/2022344,300 shares $1.57 million -9.7%N/A3 $4.56
11/30/2022381,300 shares $1.21 million +2.3%N/A2.2 $3.17
11/15/2022372,800 shares $1.13 million +12.5%N/A2.1 $3.03
10/31/2022331,500 shares $1.09 million +4.5%N/A1 $3.30
10/15/2022317,300 shares $970,938.00 -2.9%N/A1 $3.06
9/30/2022326,700 shares $1.05 million +17.8%N/A1 $3.20
9/15/2022277,300 shares $934,501.00 +2.0%1.6%0.9 $3.37
8/31/2022271,900 shares $739,568.00 -21.9%1.6%1.2 $2.72
8/15/2022347,900 shares $866,271.00 +93.0%2.0%1.7 $2.49
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

LRMR Short Interest - Frequently Asked Questions

What is Larimar Therapeutics' current short interest?

Short interest is the volume of Larimar Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 3,190,000 shares of LRMR short. Learn More on Larimar Therapeutics' current short interest.

What is a good short interest ratio for Larimar Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LRMR shares currently have a short interest ratio of 6.0. Learn More on Larimar Therapeutics's short interest ratio.

Which institutional investors are shorting Larimar Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Larimar Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Larimar Therapeutics' short interest increasing or decreasing?

Larimar Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 3,190,000 shares, an increase of 95.7% from the previous total of 1,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Larimar Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Larimar Therapeutics: Annexon, Inc. (3.99%), Fulcrum Therapeutics, Inc. (3.65%), Avid Bioservices, Inc. (15.99%), Mersana Therapeutics, Inc. (8.35%), Travere Therapeutics, Inc. (13.93%), Theravance Biopharma, Inc. (17.16%), Neurogene Inc. (7.87%), Heron Therapeutics, Inc. (17.00%), Oculis Holding AG (0.17%), Harrow Health, Inc. (17.31%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Larimar Therapeutics stock?

Short selling LRMR is an investing strategy that aims to generate trading profit from Larimar Therapeutics as its price is falling. LRMR shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Larimar Therapeutics?

A short squeeze for Larimar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LRMR, which in turn drives the price of the stock up even further.

How often is Larimar Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LRMR, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LRMR) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners